SCHEMBL6855098

SCHEMBL6855098

CCCCCCCCCc1ccccc1OPOc1cccc(CCCCCCCCC)c1CCCCCCCCC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRA P10827 1/20 0.47
THRB P10828 1/20 0.47
PTGS2 P35354 5/20 0.47
ALOX5 P09917 1/20 0.47
LTB4R Q15722 1/20 0.46
LTB4R2 Q9NPC1 1/20 0.46
PPARA Q07869 3/20 0.45
LIPG Q9Y5X9 1/20 0.44
PPARG P37231 2/20 0.43
NR1H2 P55055 1/20 0.40
NR1H3 Q13133 1/20 0.40
KCNH2 Q12809 1/20 0.40
BID P55957 3/20 0.38
MCL1 Q07820 3/20 0.38
BCL2L1 Q07817 2/20 0.38
BAK1 Q16611 2/20 0.38
KAT8 Q9H7Z6 2/20 0.38
EP300 Q09472 1/20 0.38
KAT2A Q92830 1/20 0.38
KAT2B Q92831 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4446465 0.95 PTGS2 (0.50) THRATHRBPTGS2ALOX5LTB4R
SCHEMBL4454133 0.95 PTGS2 (0.50) THRATHRBPTGS2ALOX5LTB4R
SCHEMBL6743239 0.95 PTGS2 (0.50) THRATHRBPTGS2ALOX5LTB4R
SCHEMBL4443929 0.95 PTGS2 (0.50) THRATHRBPTGS2ALOX5LTB4R
SCHEMBL6745885 0.95 PTGS2 (0.50) THRATHRBPTGS2ALOX5LTB4R
SCHEMBL1965860 0.95 PTGS2 (0.50) THRATHRBPTGS2ALOX5LTB4R
SCHEMBL4444324 0.91 THRA (0.54) THRATHRBPTGS2ALOX5PPARA
SCHEMBL6742752 0.89 PTGS2 (0.45) THRATHRBPTGS2ALOX5LTB4R
SCHEMBL28473665 0.86 PTGS2 (0.44) THRATHRBPTGS2ALOX5LTB4R
SCHEMBL10832310 0.84 THRA (0.45) THRATHRBPTGS2ALOX5PPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6784226-B2 COMPOUNDING STYRENIC RESIN WITH GREATER THAN 2 WT % WATER AND ANTIOXIDANT PREPARED BY BLENDING ORGANIC PHOSPHITE OR PHOSPHONITE WITH ACID-BINDING METAL SALT TREATED WITH SURFACE CONDITIONING AGENT CHI MEI CORPORATION (TW) 2004-08-31 US disclosed
US-20030114559-A1 Process for producing a styrenic resin composition CHI MEI CORPORATION 2003-06-19 US disclosed
US-20020002222-A1 PHOSPHORUS-CONTAINING ANTIOXIDANT STABILIZED AGAINST HYDROLYSIS CHI MEI CORPORATION (TW) 2002-01-03 US disclosed
US-4305839-A PHOSPHITES AND PHOSPHONITES FOR COLOR STABILITY CARSTAB CORPORATION (US) 1981-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020002222-A1 PHOSPHORUS-CONTAINING ANTIOXIDANT STABILIZED AGAINST HYDROLYSIS LPO, GPX4, GPX1 THRA 3787/4885THRB 4079/4885PTGS2 2332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.